Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis
- PMID: 24680562
- DOI: 10.1016/j.jns.2014.03.008
Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis
Abstract
Background: Glycogen synthase kinase-3β (GSK-3β) activity plays a central role in motor neuron degeneration. GSK-3β inhibitors have been shown to prolong motor neuron survival and suppress disease progression in amyotrophic lateral sclerosis (ALS). In this study, we evaluated the therapeutic effects of a new GSK-3b inhibitor, JGK-263, on ALS in G93A SOD1 transgenic mice.
Methods: Previously, biochemical efficacy of JGK-263 was observed in normal and mutant (G93A) hSOD1-transfected motor neuronal cell lines (NSC34). Based on these previous results, we administered JGK-263 orally to 93 transgenic mice with the human G93A-mutated SOD1 gene. The mice were divided into three groups: a group administered 20mg/kg JGK-263, a group administered 50mg/kg JGK-263, and a control group not administered with JGK-263. Clinical status, rotarod test, and survival rates of transgenic mice with ALS were evaluated. Sixteen mice from each group were selected for further biochemical study that involved examination of motor neuron count, apoptosis, and cell survival signals.
Results: JGK-263 administration remarkably improved motor function and prolonged the time until symptom onset, rotarod failure, and death in transgenic mice with ALS compared to control mice. In JGK-263 groups, choline acetyltransferase (ChAT) staining in the ventral horn of the lower lumbar spinal cord showed a large number of motor neurons, suggesting normal morphology. The neuroprotective effects of JGK-263 in ALS mice were also suggested by western blot analysis of spinal cord tissues in transgenic mice.
Conclusion: These results suggest that JGK-263, an oral GSK-3β inhibitor, is promising as a novel therapeutic agent for ALS. Still, further biochemical studies on the underlying mechanisms and safety of JGK-263 are necessary.
Keywords: ALS; Amyotrophic lateral sclerosis; GSK-3β inhibitor; Glycogen synthase kinase-3; JGK-263; Transgenic mouse.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice.J Neurol Sci. 2012 Sep 15;320(1-2):1-5. doi: 10.1016/j.jns.2012.05.038. Epub 2012 Jun 12. J Neurol Sci. 2012. PMID: 22698482
-
Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene.Eur J Neurosci. 2005 Jul;22(2):301-9. doi: 10.1111/j.1460-9568.2005.04191.x. Eur J Neurosci. 2005. PMID: 16045483
-
Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS.Exp Neurol. 2007 Jun;205(2):336-46. doi: 10.1016/j.expneurol.2007.03.004. Epub 2007 Mar 12. Exp Neurol. 2007. PMID: 17433298
-
[Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].Rinsho Shinkeigaku. 2009 Nov;49(11):814-7. doi: 10.5692/clinicalneurol.49.814. Rinsho Shinkeigaku. 2009. PMID: 20030218 Review. Japanese.
-
[Amyotrophic lateral sclerosis with the SOD1 mutations].Rinsho Shinkeigaku. 2008 Nov;48(11):966-9. doi: 10.5692/clinicalneurol.48.966. Rinsho Shinkeigaku. 2008. PMID: 19198133 Review. Japanese.
Cited by
-
Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia.Antioxidants (Basel). 2022 Nov 17;11(11):2275. doi: 10.3390/antiox11112275. Antioxidants (Basel). 2022. PMID: 36421461 Free PMC article. Review.
-
Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis.Int J Mol Sci. 2022 Feb 22;23(5):2400. doi: 10.3390/ijms23052400. Int J Mol Sci. 2022. PMID: 35269543 Free PMC article. Review.
-
New insights into Wnt signaling alterations in amyotrophic lateral sclerosis: a potential therapeutic target?Neural Regen Res. 2020 Sep;15(9):1580-1589. doi: 10.4103/1673-5374.276320. Neural Regen Res. 2020. PMID: 32209757 Free PMC article. Review.
-
The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications.Brain. 2020 Jun 1;143(6):1651-1673. doi: 10.1093/brain/awaa022. Brain. 2020. PMID: 32206784 Free PMC article. Review.
-
The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets.Int J Mol Sci. 2018 Mar 13;19(3):831. doi: 10.3390/ijms19030831. Int J Mol Sci. 2018. PMID: 29533975 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous